Clinical Trials
2 trialsNCT00070187 2013-10-17
Immunotherapy Using Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma
Children's Oncology Group
Phase 2/3 Completed
NCT00057447 2007-11-01
Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients
InterMune
Phase 1/2 Terminated